Crossmark

Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation

Crossref DOI link: https://doi.org/10.1186/s40780-020-00173-9

Published Online: 2020-08-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Trani, Antonio

Benedetto, Pietro

Di Leo, Ferdinando

Baiano, Angela

Esposito, Andrea

Menna, Danilo

Allegretti, Arianna

Cappiello, Pierluigi Antonino

Dell’Edera, Domenico https://orcid.org/0000-0002-0604-5512
License Information

Text and Data Mining valid from 2020-08-03

Version of Record valid from 2020-08-03
More Information

Article History

Received: 3 April 2020

Accepted: 18 June 2020

First Online: 3 August 2020

Ethics approval and consent to participate

: Not applicable.

: Written informed consent was obtained from the patient for publication of this case report -Chief of this journal.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below